U.S. Monoclonal Antibodies Market Estimations (2025 - 2035)

U.S. Monoclonal Antibodies Market Estimations (2025 - 2035)

The U.S. monoclonal antibodies market covers therapeutic monoclonal antibodies sold in the United States, including originator and biosimilar antibodies, naked antibodies, antibody-drug conjugates and bispecifics, given intravenously or subcutaneously, for oncology, autoimmune and inflammatory disease, neurology, infectious disease, hematology and other uses, through hospital, specialty and retail pharmacies.

📄Report ID:2515 | 📊Format: Databook | 📅Published: 18 November 2026 | ⚡Delivery: Immediate